Morbillivirus control of the interferon response: Relevance of STAT2 and mda5 but not STAT1 for canine distemper virus virulence in ferrets

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 2941-2950

  Svitek, Nicholas ^a   Gerhauser, Ingo ^b,c   Goncalves, Christophe ^a   Grabski, Elena ^d   Döring, Marius ^d   Kalinke, Ulrich ^d   Anderson, Danielle E ^b   Cattaneo, Roberto ^e   Von Messling, Veronika ^a,b,f  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^e MAYO GRADUATE SCHOOL   (United States)

^f PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; MEMBRANE PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CONTROLLED STUDY; FERRET; IMMUNE EVASION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LEUKOPENIA; LYMPHOCYTE PROLIFERATION; MALE; MEASLES VIRUS; MORBILLIVIRUS INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS INTERFERENCE; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CELL NUCLEUS; CONSERVED SEQUENCE; DISTEMPER; DISTEMPER VIRUS, CANINE; FERRETS; HUMANS; INTERFERONS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN TRANSPORT; RNA HELICASES; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 84896727796     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03076-13     Document Type: Article

References (45)

1. Schneider-Schaulies S, Schneider-Schaulies J. 2009. Measles virusinduced immunosuppression. Curr. Top. Microbiol. Immunol. 330:243-269.
2. von Pirquet CE. 1908. Das Verhalten der kutanen Tuberkulinreaktion während der Masern. Dtsch. Med. Wochenschr. 30:1297-1300.
3. Moss WJ, Griffin DE. 2006. Global measles elimination. Nat. Rev. Microbiol. 4:900-908. http://dx.doi.org/10.1038/nrmicro1550.
4. Abramson O, Dagan R, Tal A, Sofer S. 1995. Severe complications of measles requiring intensive care in infants and young children. Arch. Pediatr. Adolesc. Med. 149:1237-1240. http://dx.doi.org/10.1001/archpedi.1995 .02170240055008.
5. Dollimore N, Cutts F, Binka FN, Ross DA, Morris SS, Smith PG. 1997. Measles incidence, case fatality, and delayed mortality in children with or without vitamin A supplementation in rural Ghana. Am. J. Epidemiol. 146:646-654. http://dx.doi.org/10.1093/oxfordjournals.aje.a009330.
6. Caignard G, Bourai M, Jacob Y, Tangy F, Vidalain PO. 2009. Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus Vprotein that specifically bind STAT1 and STAT2. Virology 383:112-120. http://dx.doi.org/10.1016/j.virol.2008.10.014.
7. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, Randall R, Goodbourn S. 2007. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190-200. http://dx.doi.org/10 .1016/j.virol.2006.09.023.
8. Ramachandran A, Parisien JP, Horvath CM. 2008. STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition. J. Virol. 82:8330-8338. http://dx.doi.org/10.1128/JVI .00831-08.
9. Thomas SM, Lamb RA, Paterson RG. 1988. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54:891-902. http://dx.doi.org/10 .1016/S0092-8674(88)91285-8.
10. Cattaneo R, Kaelin K, Baczko K, Billeter MA. 1989. Measles virus editing provides an additional cysteine-rich protein. Cell 56:759-764. http://dx .doi.org/10.1016/0092-8674(89)90679-X.
11. Li T, Chen X, Garbutt KC, Zhou P, Zheng N. 2006. Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 124:105-117. http://dx.doi.org/10.1016/j .cell.2005.10.033.
12. Paterson RG, Leser GP, Shaughnessy MA, Lamb RA. 1995. The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 208:121-131. http://dx.doi.org/10.1006 /viro.1995.1135.
13. Lamb RA, Parks GD. 2013. Paramyxoviridae: the viruses and their replication, p 957-995. In Knipe DM, Howley PM (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
14. Ohno S, Ono N, Takeda M, Takeuchi K, Yanagi Y. 2004. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J. Gen. Virol. 85:2991-2999. http://dx.doi.org /10.1099/vir.0.80308-0.
15. Devaux P, von Messling V, Songsungthong W, Springfeld C, Cattaneo R. 2007. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360:72-83. http://dx.doi.org/10 .1016/j.virol.2006.09.049.
16. Rothlisberger A, Wiener D, Schweizer M, Peterhans E, Zurbriggen A, Plattet P. 2010. Two domains of the V protein of virulent canine distemper virus selectively inhibit STAT1 and STAT2 nuclear import. J. Virol. 84:6328-6343. http://dx.doi.org/10.1128/JVI.01878-09.
17. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFNinducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U. S. A. 101:17264-17269. http://dx.doi .org/10.1073/pnas.0407639101.
18. Childs KS, Andrejeva J, Randall RE, Goodbourn S. 2009. Mechanism of mda-5 inhibition by paramyxovirus V proteins. J. Virol. 83:1465-1473. http://dx.doi.org/10.1128/JVI.01768-08.
19. Ramachandran A, Horvath CM. 2010. Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference. J. Virol. 84: 11152-11163. http://dx.doi.org/10.1128/JVI.01375-10.
20. Devaux P, Hodge G, McChesney MB, Cattaneo R. 2008. Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J. Virol. 82:5359-5367. http: //dx.doi.org/10.1128/JVI.00169-08.
21. Devaux P, Hudacek AW, Hodge G, Reyes-Del Valle J, McChesney MB, Cattaneo R. 2011. A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys. J. Virol. 85:348-356. http://dx.doi.org/10.1128/JVI.00802-10.
22. von Messling V, Svitek N, Cattaneo R. 2006. Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J. Virol. 80:6084-6092. http://dx.doi.org/10.1128/JVI.00357-06.
23. von Messling V, Springfeld C, Devaux P, Cattaneo R. 2003. A ferret model of canine distemper virus virulence and immunosuppression. J. Virol. 77: 12579-12591. http://dx.doi.org/10.1128/JVI.77.23.12579-12591.2003.
24. von Messling V, Milosevic D, Cattaneo R. 2004. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc. Natl. Acad. Sci. U. S. A. 101:14216-14221. http://dx.doi.org/10.1073/pnas.0403597101.
25. Anderson DE, von Messling V. 2008. Region between the canine distemper virus Mand F genes modulates virulence by controlling fusion protein expression. J. Virol. 82:10510-10518. http://dx.doi.org/10.1128/JVI.01419-08.
26. Svitek N, von Messling V. 2007. Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets. Virology 362:404-410. http://dx.doi.org/10.1016/j.virol.2007.01.002.
27. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. 2000. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285:194-204. http://dx.doi.org/10.1006/abio.2000.4753.
28. Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM. 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 77:7635-7644. http://dx.doi.org/10.1128/JVI.77.13.7635-7644.2003.
29. Parisien JP, Bamming D, Komuro A, Ramachandran A, Rodriguez JJ, Barber G, Wojahn RD, Horvath CM. 2009. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J. Virol. 83:7252-7260. http://dx.doi.org/10.1128/JVI.00153-09.
30. Chinnakannan SK, Nanda SK, Baron MD. 2013. Morbillivirus V proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathways. PLoS One 8:e57063. http://dx.doi.org/10.1371 /journal.pone.0057063.
31. Bankamp B, Fontana JM, Bellini WJ, Rota PA. 2008. Adaptation to cell culture induces functional differences in measles virus proteins. Virol. J. 5:129. http://dx.doi.org/10.1186/1743-422X-5-129.
32. Valsamakis A, Schneider H, Auwaerter PG, Kaneshima H, Billeter MA, Griffin DE. 1998. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72:7754-7761.
33. Hller O, Kochs G, Weber F. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344:119-130. http://dx.doi.org/10.1016/j.virol.2005.09.024.
34. van Boxel-Dezaire AH, Rani MR, Stark GR. 2006. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361-372. http://dx.doi.org/10.1016/j.immuni.2006.08.014.
35. Platanias LC. 2005. Mechanisms of type-I-and type-II-interferonmediated signalling. Nat. Rev. Immunol. 5:375-386. http://dx.doi.org/10 .1038/nri1604.
36. Kallal LE, Biron CA. 2013. Changing partners at the dance: variations in STAT concentrations for shaping cytokine function and immune responses to viral infections. JAKSTAT 2(1):e23504. http://dx.doi.org/10 .4161/jkst.23504.
37. Uddin S, Majchrzak B, Woodson J, Arunkumar P, Alsayed Y, Pine R, Young PR, Fish EN, Platanias LC. 1999. Activation of the p38 mitogenactivated protein kinase by type I interferons. J. Biol. Chem. 274:30127-30131. http://dx.doi.org/10.1074/jbc.274.42.30127.
38. Najjar I, Fagard R. 2010. STAT1 and pathogens, not a friendly relationship. Biochimie 92:425-444. http://dx.doi.org/10.1016/j.biochi.2010.02 .009.
39. Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, Casanova JL. 2012. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr. Opin. Immunol. 24:364-378. http://dx.doi.org/10.1016/j.coi.2012.04.011.
40. Hahm B, Trifilo MJ, Zuniga EI, Oldstone MB. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22:247-257. http://dx.doi .org/10.1016/j.immuni.2005.01.005.
41. Lemon K, de Vries RD, Mesman AW, McQuaid S, van Amerongen G, Yuksel S, Ludlow M, Rennick LJ, Kuiken T, Rima BK, Geijtenbeek TB, Osterhaus AD, Duprex WP, de Swart RL. 2011. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog. 7:e1001263. http://dx.doi.org/10.1371/journal.ppat.1001263.
42. Bao M, Liu YJ. 2013. Regulation of TLR7/9 signaling in plasmacytoid dendritic cells. Protein Cell 4:40-52. http://dx.doi.org/10.1007/s13238-012-2104-8.
43. Pfaller CK, Conzelmann KK. 2008. Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J. Virol. 82:12365-12373. http://dx.doi .org/10.1128/JVI.01321-08.
44. Marié I, Durbin JE, Levy DE. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669. http://dx.doi.org/10.1093/emboj/17.22 .6660.
45. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, Tanaka N. 1998. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441:106-110. http://dx.doi.org/10 .1016/S0014-5793(98)01514-2.